Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder (Q34537344)

2 August 2017

1 reference

title

Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

2 August 2017

main subject

0 references

author

Dan J. Stein

series ordinal

4

1 reference

2 August 2017

3

Soraya Seedat

0 references

Brian Harvey

object named as

Brian H Harvey

series ordinal

1

0 references

author name string

Christiaan B Brink

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

2 August 2017

published in

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

21-32

1 reference

Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

How accurately can we image inositol lipids in living cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

The Mechanism of Muscarinic Receptor‐Stimulated Phosphatidylinositol Resynthesis in 1321N1 Astrocytoma Cells and Its Inhibition by Li+

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Alternative splicing of the human serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

5HT2C CYS23/SER23 polymorphism is not associated with obsessive–compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Regulation of 5-HT receptors by corticosteroids: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol as an add-on treatment for bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol has behavioral effects with adaptation after chronic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Molecular determinants of metabotropic glutamate receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Chronic epi-inositol has an anxiolytic-like effect in the plus-maze model in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Augmentation of lithium's behavioral effect by inositol uptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Effect of inositol treatment on the behavior of rhesus monkeys: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Rat brain monoamines after acute and chronic myo-inositol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Neurobiology of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Affective Disorders and Nitric Oxide: A Role in Pathways to Relapse and Refractoriness?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Chronic inositol increases striatal D(2) receptors but does not modify dexamphetamine-induced motor behavior. Relevance to obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Initiation and adaptation: a paradigm for understanding psychotropic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Toward a neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Chronic dietary inositol enhances locomotor activity and brain inositol levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Controlled trials of inositol in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol treatment raises CSF inositol levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Double-blind, controlled trial of inositol treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol treatment of autism

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Glucocorticoid-biogenic amine interactions in relation to mood and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Signal transduction through beta-catenin and specification of cell fate during embryogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Regulation of second messengers by the inositol polyphosphate 5-phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Is the 5-HT1DβReceptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: an open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Inositol in the treatment of trichotillomania and compulsive skin picking

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Lithium therapy and signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900244-5

7 January 2021

10.1016/S0278-5846(01)00244-5

Identifiers

DOI

1 reference

2 August 2017

1 reference